Abstract
In the late 1980s, investigators showed that treatment with intravenous immunoglobulin (IVIG) reduces the incidence of coronary artery aneurysms (CAAs) in children with Kawasaki disease (KD). Nevertheless, CAAs still occur in some children with KD. To determine the risk factors for CAA in the era of routine IVIG treatment, researchers conducted a retrospective case-control study of patients …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
